However, a significant increase in the level of circulating exosomal PD-L1 after several weeks of treatment would be a predictor of the adaptive response of the tumor cells to T-cell reinvigoration, stratifying the non-responders in the clinic. This evidence concerns the gene CD274 and neoplasm.